phenytoin has been researched along with Cytomegalic Inclusion Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yukawa, M | 1 |
| Iizuka, M | 1 |
| Sasaki, K | 1 |
| Horie, Y | 1 |
| Shirasaka, T | 1 |
| Kon-no, S | 1 |
| Watanabe, S | 1 |
| Lee, KC | 1 |
| Garcia, PA | 1 |
| Alldredge, BK | 1 |
| Andersen, P | 1 |
| Alacam, R | 1 |
| Andersen, I | 1 |
| Andersen, HK | 1 |
| Eizuru, Y | 1 |
| Minamishima, Y | 1 |
| Matsumoto, T | 1 |
| Hamakado, T | 1 |
| Mizukoshi, M | 1 |
| Nabeshima, K | 1 |
| Koono, M | 1 |
| Yoshida, A | 1 |
| Yoshida, H | 1 |
| Kikuchi, M | 1 |
| Aihara, M | 1 |
| Sugita, Y | 1 |
| Takahashi, S | 1 |
| Nagatani, T | 1 |
| Arata, S | 1 |
| Takeuchi, K | 1 |
| Ikezawa, Z | 1 |
5 other studies available for phenytoin and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Administration of phenytoin and cytomegalovirus infection in the terminal ileum.
Topics: Aged; Anticonvulsants; Cytomegalovirus Infections; Diagnosis, Differential; Epilepsy; Female; Humans | 2002 |
Clinical features of status epilepticus in patients with HIV infection.
Topics: Adult; Anti-Retroviral Agents; Anticonvulsants; Benzodiazepines; Brain Neoplasms; Central Nervous Sy | 2005 |
Cytomegalovirus antibodies in epileptics receiving diphenylhydantoin.
Topics: Adolescent; Adult; Antibodies, Viral; Antibody Formation; Cytomegalovirus; Cytomegalovirus Infection | 1982 |
Application of in situ hybridization with a novel phenytoin-labeled probe to conventional formalin-fixed, paraffin-embedded tissue sections.
Topics: Adrenal Glands; Cytomegalovirus; Cytomegalovirus Infections; DNA Probes; Female; Formaldehyde; Human | 1995 |
Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus.
Topics: Anticonvulsants; Cytomegalovirus; Cytomegalovirus Infections; Drug Eruptions; Drug Hypersensitivity; | 2001 |